BRR : 9742847
Tender Brief : Procurement Of Drugs/Medicines/Iv Fluids , Drugs , Tab. Chlorzoxazone+ Paracetamol+ Diclofenac 250Mg+325Mg+50Mg , Inj. Propofol Mct-Lct2% W/V 20Mg/Ml , Plastic P.D. Fluid (Capd Bags) 1.5% 2 Ltr , Plastic P.D. Fluid (Capd Bags) 2.5% 2 Ltr , Inj. Nivolumab 40Mg , Inj. Nivolumab 100Mg , Inj. Purified Vi Conjugate Ploysaccharide Typhoid Vaccine25mcg , Tab. Loralatinib 100Mg , Tab. Enalapril2.5Mg , Inj. Mepolizumab 100Mg , Cream/Oint Betamethasone + Clioquinol 0.1%+ 3% (30Gm) , Inj. Golimumab 50Mg 0.5Ml , Tab. Ivabradine 5Mg , Inj. Pembrolizumab 100Mg , Tablet Endoxifen 8 Mg , Oint. Mometasone 0.1... Read More
Tender Value
₹
Ref. Document
Submission Date
18-08-2025
Participated Bidder List
19 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics | |||||
| 2 | cnet-technologies | Bid Analytics | |||||
| 3 | cnet-technologies | Bid Analytics | |||||
| 4 | cnet-technologies | Bid Analytics | |||||
| 5 | cnet-technologies | Bid Analytics | |||||
| 6 | cnet-technologies | Bid Analytics | |||||
| 7 | cnet-technologies | Bid Analytics | |||||
| 8 | cnet-technologies | Bid Analytics | |||||
| 9 | cnet-technologies | Bid Analytics | |||||
| 10 | cnet-technologies | Bid Analytics | |||||
| 11 | cnet-technologies | Bid Analytics | |||||
| 12 | cnet-technologies | Bid Analytics | |||||
| 13 | cnet-technologies | Bid Analytics | |||||
| 14 | cnet-technologies | Bid Analytics | |||||
| 15 | cnet-technologies | Bid Analytics | |||||
| 16 | cnet-technologies | Bid Analytics | |||||
| 17 | cnet-technologies | Bid Analytics | |||||
| 18 | cnet-technologies | Bid Analytics | |||||
| 19 | cnet-technologies | Bid Analytics |
Work Detail
procurement of drugs/medicines/iv fluids , drugs , tab. chlorzoxazone+ paracetamol+ diclofenac 250mg+325mg+50mg , inj. propofol mct-lct2% w/v 20mg/ml , plastic p.d. fluid (capd bags) 1.5% 2 ltr , plastic p.d. fluid (capd bags) 2.5% 2 ltr , inj. nivolumab 40mg , inj. nivolumab 100mg , inj. purified vi conjugate ploysaccharide typhoid vaccine25mcg , tab. loralatinib 100mg , tab. enalapril2.5mg , inj. mepolizumab 100mg , cream/oint betamethasone + clioquinol 0.1%+ 3% (30gm) , inj. golimumab 50mg 0.5ml , tab. ivabradine 5mg , inj. pembrolizumab 100mg , tablet endoxifen 8 mg , oint. mometasone 0.1% (15gm) , inj. mitoxantrone 20 mg , inj. pancuronium bromide 4mg 2ml , inj.insulin degludec disposable pen with penfill 100 iu , insulin degludec+ insulin aspart pen with penfill2.56mg/1ml+ 1.05mg/1ml , tab. ribociclib200mg , tab. flavonoids containing micronize extract of rutaceae eq to diosmin 450mg +50 hesperidine 500 mg , inj. somatrogon 24mg pfp , syp. combination of aluminium hydoxide magneshium hydro-xide/trisilicate simethicone, activated methyl polysilox etc. 150ml-200ml , inj. cefoperazone 1gm , tab deflazacort 24mg , oint. clobetasol 0.05%w/w (30gm) , tab. deflazacort 30mg , tab acenocoumarol 1mg , inj. 6%isotonic balanced hydroxy ethyl starch based colloid solution. electrolyte composition similar to plasma. na+ 135to 140 mmol/l cl- 110 to120mmol/lk+ 3.5 to 4.5 mmol/l containing adequate acetate, malate osmolality 285 to 300 mosm/l , inj. rapid acting insulin vial , inj. avelumab 200mg/10ml , injection risperidone injection (long acting) 25 mg , injection risperidone injection (long acting) 37.5 mg , injection glyceryl trinitrate 5 mg/ml , tabletartemether 40 mg + lumefantrine 240 mg , capsule aprepitant 80 mg , tab. gilteritinib 40mg , tablet quinine300 mg , tablet tenofovir disproxil fumarate 300 mg + lamivudine 300 mg + efavirenz 600 mg , tablettenofovir disproxil fumarate 300 mg + lamivudine 300 mg + dolutegravir 50 mg , e/d ofloxacin + dexamethason0.3 % + 0.1 % , topicallidocaine 2% to 4% (hydrochloride) , injection cetuximab 500mg , injection daratumumab 100mg , injection daratumumab 400mg , injection lignocaine hcl (topical) 42.7mg/ml 4% (30 ml) , injection thiopentone 500mg , tablet dabrafenib mesylate 75mg , fluid icodextrin 7.5% 2lt , inj. follitropin alfa and lutropin alfa(900iu rhfsh + 450rhlh) 1.44 solution pfp , suppository paracetamol 80mg , suppository paracetamol suppository 170 mg , injection secukinumab 150mg , injectionsodium diatrizoate & meglumine diatrizoate 76% - pack of 50ml , injection metoprolol 5 mg 5ml , tablet s-atenolol 25mg , tablet carbamazepine controlled release 200mg , eyedrop combination of boric acid, naphazoline etc1.1% w/v+ 0.01% w/v (5 ml) , ointment framycetin 1% (20gm) , syrup metronidazole 200mg , tablet metronidazole 200 mg , tablet sodium picosulfate 10 mg , tablet magnesium hydroxide, aluminum hydroxide, simethicone 185mg+830mg+50mg , syrup prednisolone 5mg/5ml (60ml) , tab. calcitriol 0.25 mcg , injection insulin aspart biosynthetic & meta cresol penfill with pen 300 iu (3ml) , injection insulin aspart premix analogue 30/70 pen 3 ml , inj. human albumin low sodium/ salt contains less than 80mmol/l 100ml 20% 100ml , inj. human albumin low sodium/ salt contains less than 80mmol/l 50ml 20% 50ml
View Original Notice/Document
Result Documents
Tender Documents
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
Technical Evaluation In Progress
Technical bid evaluation is currently in progress. Awarded bidder details will be available after completion of technical scrutiny.
TechnicalBid
Similar Tenders Results